Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2021 |
| Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Institucional do Centro Universitário La Salle |
| Texto Completo: | http://hdl.handle.net/11690/1780 |
| id |
UNILASALLE_e093548b6defc7d99ba8419b9b45c817 |
|---|---|
| oai_identifier_str |
oai:svr-net20.unilasalle.edu.br:11690/1780 |
| network_acronym_str |
UNILASALLE |
| network_name_str |
Repositório Institucional do Centro Universitário La Salle |
| repository_id_str |
|
| spelling |
Veiga, Viviane C.Prats, João A. G. G.Farias, Danielle L. C.Rosa, Regis G.Dourado, Leticia K.Zampieri, Fernando G.Machado, Flávia R.Lopes, Renato D.Berwanger, OtavioAzevedo, Luciano C. P.Avezum, ÁlvaroLisboa, ThiagoRojas, Salomón S. O.Coelho, Juliana C.Leite, Rodrigo T.Carvalho, Júlio C.Andrade, Luis E. C.Sandes, Alex F.Pintão, Maria C. T.Castro Junior, Claudio G.Santos, Sueli V.de Almeida, Thiago M. L.Costa, André N.Gebara, Otávio C. E.Freitas, Flávio G. Rezende dePacheco, Eduardo S.Machado, David J. B.Martin, JosianeConceição, Fábio G.Siqueira, Suellen R. R.Damiani, Lucas P.Ishihara, Luciana M.Schneider, DanielSouza, Denise deCavalcanti, Alexandre B.Scheinberg, Phillip2021-07-08T19:57:41Z2021-07-08T19:57:41Z2021VEIGA, V. C. et al. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ, v. 372, n. 84, jun. 2021. Disponível em: http://hdl.handle.net/11690/1780. Acesso em: 08 jul. 2021.http://hdl.handle.net/11690/1780Submitted by DSpace Unilasalle (dspace@unilasalle.edu.br) on 2021-07-08T19:57:41Z No. of bitstreams: 1 Effect Tocilizumab_BMJ.pdf: 431355 bytes, checksum: 83c2f6347869beeb8527bbcf4a8a36c5 (MD5)Made available in DSpace on 2021-07-08T19:57:41Z (GMT). No. of bitstreams: 1 Effect Tocilizumab_BMJ.pdf: 431355 bytes, checksum: 83c2f6347869beeb8527bbcf4a8a36c5 (MD5) Previous issue date: 2021BMJ Publishing GroupCOVID-19Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trialinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessengreponame:Repositório Institucional do Centro Universitário La Salleinstname:Universidade La Salle (UNILASALLE)instacron:UNILASALLEORIGINALEffect Tocilizumab_BMJ.pdfEffect Tocilizumab_BMJ.pdfOpen Accessapplication/pdf431355http://svr-net20.unilasalle.edu.br:8080/jspui/bitstream/11690/1780/1/Effect%20Tocilizumab_BMJ.pdf83c2f6347869beeb8527bbcf4a8a36c5MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://svr-net20.unilasalle.edu.br:8080/jspui/bitstream/11690/1780/2/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5211690/17802021-07-08 16:58:38.591oai:svr-net20.unilasalle.edu.br: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Repositório Institucionalopendoar:2021-07-08T19:58:38Repositório Institucional do Centro Universitário La Salle - Universidade La Salle (UNILASALLE)false |
| dc.title.pt_BR.fl_str_mv |
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial |
| title |
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial |
| spellingShingle |
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial Veiga, Viviane C. COVID-19 |
| title_short |
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial |
| title_full |
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial |
| title_fullStr |
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial |
| title_full_unstemmed |
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial |
| title_sort |
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial |
| author |
Veiga, Viviane C. |
| author_facet |
Veiga, Viviane C. Prats, João A. G. G. Farias, Danielle L. C. Rosa, Regis G. Dourado, Leticia K. Zampieri, Fernando G. Machado, Flávia R. Lopes, Renato D. Berwanger, Otavio Azevedo, Luciano C. P. Avezum, Álvaro Lisboa, Thiago Rojas, Salomón S. O. Coelho, Juliana C. Leite, Rodrigo T. Carvalho, Júlio C. Andrade, Luis E. C. Sandes, Alex F. Pintão, Maria C. T. Castro Junior, Claudio G. Santos, Sueli V. de Almeida, Thiago M. L. Costa, André N. Gebara, Otávio C. E. Freitas, Flávio G. Rezende de Pacheco, Eduardo S. Machado, David J. B. Martin, Josiane Conceição, Fábio G. Siqueira, Suellen R. R. Damiani, Lucas P. Ishihara, Luciana M. Schneider, Daniel Souza, Denise de Cavalcanti, Alexandre B. Scheinberg, Phillip |
| author_role |
author |
| author2 |
Prats, João A. G. G. Farias, Danielle L. C. Rosa, Regis G. Dourado, Leticia K. Zampieri, Fernando G. Machado, Flávia R. Lopes, Renato D. Berwanger, Otavio Azevedo, Luciano C. P. Avezum, Álvaro Lisboa, Thiago Rojas, Salomón S. O. Coelho, Juliana C. Leite, Rodrigo T. Carvalho, Júlio C. Andrade, Luis E. C. Sandes, Alex F. Pintão, Maria C. T. Castro Junior, Claudio G. Santos, Sueli V. de Almeida, Thiago M. L. Costa, André N. Gebara, Otávio C. E. Freitas, Flávio G. Rezende de Pacheco, Eduardo S. Machado, David J. B. Martin, Josiane Conceição, Fábio G. Siqueira, Suellen R. R. Damiani, Lucas P. Ishihara, Luciana M. Schneider, Daniel Souza, Denise de Cavalcanti, Alexandre B. Scheinberg, Phillip |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Veiga, Viviane C. Prats, João A. G. G. Farias, Danielle L. C. Rosa, Regis G. Dourado, Leticia K. Zampieri, Fernando G. Machado, Flávia R. Lopes, Renato D. Berwanger, Otavio Azevedo, Luciano C. P. Avezum, Álvaro Lisboa, Thiago Rojas, Salomón S. O. Coelho, Juliana C. Leite, Rodrigo T. Carvalho, Júlio C. Andrade, Luis E. C. Sandes, Alex F. Pintão, Maria C. T. Castro Junior, Claudio G. Santos, Sueli V. de Almeida, Thiago M. L. Costa, André N. Gebara, Otávio C. E. Freitas, Flávio G. Rezende de Pacheco, Eduardo S. Machado, David J. B. Martin, Josiane Conceição, Fábio G. Siqueira, Suellen R. R. Damiani, Lucas P. Ishihara, Luciana M. Schneider, Daniel Souza, Denise de Cavalcanti, Alexandre B. Scheinberg, Phillip |
| dc.subject.por.fl_str_mv |
COVID-19 |
| topic |
COVID-19 |
| publishDate |
2021 |
| dc.date.accessioned.fl_str_mv |
2021-07-08T19:57:41Z |
| dc.date.available.fl_str_mv |
2021-07-08T19:57:41Z |
| dc.date.issued.fl_str_mv |
2021 |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
VEIGA, V. C. et al. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ, v. 372, n. 84, jun. 2021. Disponível em: http://hdl.handle.net/11690/1780. Acesso em: 08 jul. 2021. |
| dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/11690/1780 |
| identifier_str_mv |
VEIGA, V. C. et al. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ, v. 372, n. 84, jun. 2021. Disponível em: http://hdl.handle.net/11690/1780. Acesso em: 08 jul. 2021. |
| url |
http://hdl.handle.net/11690/1780 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
BMJ Publishing Group |
| publisher.none.fl_str_mv |
BMJ Publishing Group |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional do Centro Universitário La Salle instname:Universidade La Salle (UNILASALLE) instacron:UNILASALLE |
| instname_str |
Universidade La Salle (UNILASALLE) |
| instacron_str |
UNILASALLE |
| institution |
UNILASALLE |
| reponame_str |
Repositório Institucional do Centro Universitário La Salle |
| collection |
Repositório Institucional do Centro Universitário La Salle |
| bitstream.url.fl_str_mv |
http://svr-net20.unilasalle.edu.br:8080/jspui/bitstream/11690/1780/1/Effect%20Tocilizumab_BMJ.pdf http://svr-net20.unilasalle.edu.br:8080/jspui/bitstream/11690/1780/2/license.txt |
| bitstream.checksum.fl_str_mv |
83c2f6347869beeb8527bbcf4a8a36c5 8a4605be74aa9ea9d79846c1fba20a33 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional do Centro Universitário La Salle - Universidade La Salle (UNILASALLE) |
| repository.mail.fl_str_mv |
|
| _version_ |
1797047739408711680 |